SCOLR Pharma, Inc.
DelistedCIK 934936fmd_055F583TX2EH33G67XQHM9PKKSManufacturing · In Vitro & In Vivo Diagnostic SubstancesTemplate: Standard
Coverage: Jan 01, 2010 to Sep 30, 2011, 4 periods
Latest quarter · Q3 FY2011
Millions- Total revenues
- 0
- Operating income
- (1)
- Net income
- (1)